Allarda, Ginajane .

HRN: 23-86-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
CEFUROXIME 1.5GM (VIAL)
10/28/2023
10/29/2023
IV
1.5 G
Loading Dose
For Stat CS For NRFS
Waiting Final Action 
10/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/28/2023
10/29/2023
IV
500mg
Loading Dose
For Stat Cs For NRFS With Thickly MSAF
Waiting Final Action 
10/28/2023
CEFUROXIME 1.5GM (VIAL)
10/28/2023
10/30/2023
IVT
1.5g
Q8 X 6 Doses
S/p Primary LTCS
Waiting Final Action 
10/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/28/2023
10/30/2023
IVT
500mg
Q8 X 6 Doses
S/p Primary LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: